1. Date & Time | Opening Date | Time | |
From | To | From | To |
2022-03-04 | 2022-03-04 | 14:00 | 17:00 |
2. Place | Seoul | ||
3. Participant | Sell-side analysts in the pharmaceutical/biotech sector | ||
4. Purpose | Introducing RNAi drug development progress a nd pipeline | ||
5. Method | Analyst's Day Event | ||
6. Major Contents | ○ BIO EUROPE SPRING 2022 Preview 1. Progress update on a new drug candidate for fibrosis 2. Progress update on hair-loss(androgenic alopecia) related new drug candidate, in European cosmeceuticals and US OTC drugs market 3. Introduction to previously undisclosed pipelines, including research results that have penetrated the blood-brain barrier (BBB) 4. J.P. Morgan Healthcare Conference follow-up meeting progress 5. Q&A | ||
7. Sponsor | self-organized | ||
8. Opening Decision Date | 2022-02-25 | ||
9. Person in charge of IR | Department(Name) | IR Division(D.H Linus Hwang, Head of IR) | |
Contact Number(Fax Number) | 02-739-6083 (02-6303-0046) | ||
10. IR Material Publication | Publication Date | 2022-03-04 | |
Publication Place |
- KRX Kind System (http://kind.krx.co.kr) - IR page on our website |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Bioneer Corporation published this content on 25 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 February 2022 07:21:05 UTC.